Shore Capital Partners (“Shore” or “Shore Capital”), a Chicago-based private equity firm with offices in Nashville, is pleased to announce the launch of Agentis Longevity (“Agentis” or the “Company”), a new, innovative platform dedicated to advancing comprehensive longevity healthcare.
Based in Nashville, Agentis aims to redefine healthy aging by delivering a suite of services designed to extend health span, optimize vitality, and address age-related conditions. Jimmy St Louis, veteran healthcare operator, will serve as Agentis’ Chief Executive Officer. Prior to this role, St Louis was Founder and CEO of two innovative healthcare businesses, Regenerative Medicine Solutions and AlliRx, and was COO at Laser Spine Institute. He is also a former professional football player for the Tennessee Titans.
HealthTech Insights: Cepham Increases Commitment to Men’s Health With Emphasis on Wellbeing and Plant-Based Ayurvedic Care
“The longevity marketplace is primed for bold leadership, and I am inspired by the opportunity to help people live a life of wellness while addressing unmet needs in healthcare. The name Agentis is indicative of taking powerful action to make a difference for our patients and family members, and this journey is deeply personal to me. Coming from a medical family, I am driven by the belief that quality of life and length of life should go hand in hand. Partnering with Shore Capital is a dream realized—it brings the resources, expertise and support needed to truly make a transformative difference in the lives of healthcare consumers. Together, we are shaping a future where vitality and innovation meet to empower healthier, happier lives,” said St Louis.
HealthTech Insights: Kyan Health raises $16.7M to upgrade workplace wellness with AI-powered preventative care
“The goal of Agentis is to empower patients to take ownership of their health to live longer, happier and healthier lives,” said Logan Pitts, Vice President at Shore. “We’ve found that American consumers are increasingly motivated to prioritize proactively managing their health, whether it be how they feel or how they look, and we are excited to announce another Shore platform investment aligned with the growing theme of consumerization in healthcare.”
Chris Mioton, Partner at Shore, added, “We believe that the early-stage growth of the consumer longevity market presents an opportunity to become a national leader. By combining cutting-edge services and products with robust clinical practices and education, we see a tremendous opportunity to shape the future of longevity healthcare.”
Agentis will focus on delivering comprehensive care to its patients, including hormone optimization therapy, detailed health testing, weight management, peptides, stem cells and other innovative therapies. St Louis added, “We are actively building the leading longevity platform across the U.S. Agentis is partnering with best-in-class providers and enabling outsized growth through strategic marketing, robust new clinic openings and operational excellence. Our mission is to provide the resources, know-how and multi-site operations experience to enable these practices to deliver even better care to a larger patient base.”
Agentis has assembled a world-class management team and Board of Directors, uniting leading experts in multi-site healthcare, innovative care delivery models, and the forefront of longevity medicine. Agentis’ independent board members include: Dino Eliopoulos, CEO of Behavioral Innovations; David Barr, Lead Independent Director of Empower Aesthetics; Dylan Jackson, COO of BrightView; George Koveos, COO of Mixlab; Dr. Stephen Klasko, Executive in Residence at General Catalyst; and Dr. Sara Gottfried Szal, Director of Precision Medicine and Clinical Assistant Professor in the Department of Integrative Medicine and Nutritional Sciences at the Thomas Jefferson University Sidney Kimmel Medical College. Their collective expertise will drive the company’s expansion strategy, which includes strategic acquisitions and new clinic openings in key markets.
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – Businesswire
